Spok Holdings, Inc. (SPOK)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-09
$10.57-0.66%
Close 2026-09-09 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-09
Intact: The reason to own it still holds.
Spok maintains a steady quarterly dividend of $0.3125 per share. The company guides revenue near $139.5 million for 2026. Adjusted EBITDA is expected around $32.5 million. The stock trades cheap with a P/E of 17.5 versus peers at 28.4.
Spok has missed earnings multiple times recently. Revenue and operating income declined in early 2026. Dividend sustainability is questioned by some analysts. Growth is expected to be flat, limiting upside.
The price is about 47% below our fair value near $20. Analysts expect near zero revenue growth. The market prices in limited growth but values the stock cheaply versus peers.
Breaks if: Adjusted EBITDA falls below $27.5 million in FY26
Breaks if: Dividend per share is cut or suspended
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a multi-year view on a company that operates in the healthcare sector, which currently has a supportive backdrop. The thesis is intact, but there are elevated risks that could impact performance.
The market appears to have priced in a cheap valuation compared to peers, with an expectations gap suggesting that investors are not overly optimistic. The current valuation reflects a low level of fragility.
Recent financial performance has been strong, but there is a medium risk of missing future earnings expectations. Management is focused on cost reduction and investing in AI and product development, which could support future performance.
The thesis hinges on management's ability to execute their cost-saving strategies and the performance of the broader healthcare sector. Key factors include whether sector leaders continue to report strong earnings and guidance.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue paying a regular quarterly dividend of $0.3125 per share to return capital to stockholders.
Stated as a priority in 3 consecutive quarters from 2025-Q4 through 2026-Q2. The Board consistently declared a quarterly dividend of $0.3125 per share. Dividend payments have been maintained steadily, demonstrating consistent capital return to stockholders as committed.
“Board declared a regular quarterly dividend of $0.3125 per share payable on September 9, 2026”
“Board declared a regular quarterly dividend of $0.3125 per share payable on June 24, 2026”
“Board declared a regular quarterly dividend of $0.3125 per share payable on March 31, 2026”
Breaks if: Revenue falls below $136 million in FY26
Maintain the full year 2026 revenue guidance range of $136M to $143M.
In the next 1 to 3 years, SPOK's performance will depend on its operational execution and sector dynamics. Not investment advice.